Compositional and functional alteration of gut microbiota profiles in response to anti-TNF-α therapy in inflammatory bowel disease: A Pilot study-Reference-Cited by-同舟云学术

Compositional and functional alteration of gut microbiota profiles in response to anti-TNF-α therapy in inflammatory bowel disease: A Pilot study

Published:2024 Issue: Volume:44 Page:101415
ISSN:2352-9148
Container-title:Informatics in Medicine Unlocked
language:en
Short-container-title:Informatics in Medicine Unlocked

Author:

Al Shehri Dikhnah^ORCID,Saadah Omar I.,Mosli Mahmoud^ORCID,Edris Sherif,Alatawy Marfat,Alatawi Hanan,Al-Amrah Hadba,Alatwi Ibrahim^ORCID,Al-Hindi Rashad,Bahieldin Ahmad^ORCID

Funder

King Abdulaziz University

Publisher

Elsevier BV

Subject

Health Informatics

Reference48 articles.

1. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome;Khan;Pathogens,2019

2. The intersection of TNF, IBD and the microbiome;Jones-Hall;Gut Microb,2016

3. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis;Machiels;Gut,2014

4. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment;Morgan;Genome Biol,2012

5. Al-Amrah H, S.O., Mosli M, Edris S, AlhindiI R, Bahieldin A. Alteration of the gut microbiome for patients with Inflammatory Bowel Disease: a review. Appl Ecol Environ Res.18(5):7379-7392..

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative analysis of Parkinson’s disease and inflammatory bowel disease gut microbiomes highlights shared depletions in key butyrate-producing bacteria;2024-04-29